Abstract: A liquid crystal display includes: a first insulation substrate; a gate line disposed on the first insulation substrate; a first data line and a second data line disposed on the first insulation substrate; a color filter disposed on the first insulation substrate and disposed between the first data line and the second data line; a first light blocking member disposed on the first data line and the second data line; and a second light blocking member disposed on the color filter and the first light blocking member, extending in the same direction as the gate line, and overlapping the first light blocking member on the first data line and the second data line.

Abstract: The present invention relates to a liquid formulation of long-acting insulinotropic peptide conjugate, comprising a pharmaceutically effective amount of long-acting insulinotropic peptide conjugate consisting of a physiologically active peptide, insulinotropic peptide, and an immunoglobulin Fc region; and an albumin-free stabilizer, wherein the stabilizer comprises a buffer, a sugar alcohol, a non-ionic surfactant, and an isotonic agent, and a method for preparing the formulation. For the purpose of preventing microbial contamination, a preservative may be added. The liquid formulation of the present invention is free of human serum albumin and other potentially hazardous factors to body, having no risk of viral contamination, and thus can provide excellent storage stability for insulinotropic peptide conjugates at high concentration.

Abstract: The present invention relates to a liquid formulation of long-acting insulin conjugate, comprising a pharmaceutically effective amount of a long-acting insulin conjugate, wherein a physiologically active peptide, which is an insulin, is linked to an immunoglobulin Fc region; and an albumin-free stabilizer, wherein the stabilizer comprises a buffer, a sugar alcohol, a non-ionic surfactant, and an isotonic agent, and a method for preparing the formulation. For preventing microbial contamination in multiple uses, a preservative can be added to the formulation. The liquid formulation of the present invention does not comprise a human serum albumin and potentially hazardous factors to body, and thus it has excellent storage stability for insulin conjugate without a risk of viral infection.

Abstract: A display panel includes a first substrate, a first thin film transistor disposed on the first substrate, a color filter disposed on the first thin film transistor, a passivation layer disposed on the color filter, a first opening being formed through the passivation layer and extending into the color filter, and a first pixel electrode disposed on the passivation layer, electrically connected to the first thin film transistor, and overlapping the first opening.

Abstract: Disclosed is a liquid formulation of long-acting human growth hormone (hGH) conjugate, free of albumin, which can guarantee the stability of the long-acting hGH conjugate when stored over a long period of time, wherein the long-acting human growth hormone conjugate includes a human growth hormone linked to an immunoglobulin Fc region, and has a prolonged in vivo stability compared to the native form. The liquid formulation of hGH conjugate including a pH 5.0˜6.0 buffer, a sugar alcohol, a salt and a non-ionic surfactant is free of human serum albumin and other hazardous factors which are potentially contaminated with viruses, and can provide excellent storage stability customized for a long-acting hGH conjugate composed of an hGH polypeptide and an immunoglobulin Fc region which has higher molecular weight and in vivo durability, compared to the native.

Abstract: A manufacturing method of a liquid crystal display includes: providing a lower mother substrate including a plurality of lower panels including thin film transistors and coated with a lower alignment layer, providing an upper mother substrate including a plurality of upper panels respectively corresponding to the plurality of lower panels and coated with an upper alignment layer, forming a mother substrate assembly by forming a liquid crystal mixture layer including a liquid crystal between the lower mother substrate and the upper mother substrate and combining the lower mother substrate and the upper mother substrate, dividing each upper panel into a first region, a second region, and a third region by forming three cutting lines for each upper panel at the upper mother substrate of the mother substrate assembly; applying a voltage to the first region and the third region of the upper mother substrate that is not covered by the lower mother substrate and exposed to pretilt the liquid crystal, and irradiating

Abstract: A display substrate includes a base substrate, a thin-film transistor (TFT), a color filter and a pixel electrode. The TFT is on the base substrate. The color filter is on the base substrate including the TFT and in contact with the base substrate. The pixel electrode is on the color filter and in electrical connection to a drain electrode of the TFT.

Abstract: The present invention relates to a liquid formulation of highly concentrated long-acting human growth hormone conjugate, comprising a pharmaceutically effective amount of the long-acting human growth hormone conjugate in which human growth hormone (hGH) is linked to an immunoglobulin Fc region, and an albumin-free stabilizer, said stabilizer comprising a buffer, a non-ionic surfactant, a sugar alcohol, and sodium chloride as an isotonic agent, and a method for preparing the same.

Abstract: A display panel includes a gate line extending substantially in a first direction, a first data line extending in a second direction substantially perpendicular to the first direction and a first switching element comprising a first electrode, a second electrode and a channel layer, where an end portion of the first electrode has a first edge oriented substantially perpendicular to a direction of extension of the first electrode, and the second electrode extends in a direction substantially opposite to the first electrode and an end portion of the second electrode has a second edge oriented substantially perpendicular to a direction of extension of the second electrode, and the channel layer substantially entirely covers both a lower surface of the first electrode and a lower surface of the second electrode.

Abstract: A method of manufacturing a liquid crystal display includes: preparing a lower mother substrate, where lower cells, each including a thin film transistor, are provided on the lower mother substrate, and a lower alignment layer is disposed on the lower cells; preparing an upper mother substrate, where upper cells corresponding to the lower cells are provided on the upper mother substrate, and an upper alignment layer is disposed on the upper cells; providing a mother substrate assembly by providing a liquid crystal mixture layer between the lower and upper mother substrates and combining the lower and upper mother substrates; providing a pretilt of the liquid crystals by applying a voltage to a voltage application unit of the lower mother substrate; and curing an alignment supporting agents in the liquid crystal mixture layer or the lower and upper alignment layers by irradiating light to a side of the mother substrate assembly.

Abstract: An array substrate includes a base substrate and a contact part. The contact part is disposed on the base substrate. The contact part includes a first metal pattern, a disconnection control pattern and a connecting pattern. The second metal pattern is disposed on a layer different from the first metal pattern, the disconnection control pattern overlaps a side surface of the second metal pattern and a connecting pattern is formed on the first and second metal patterns and the disconnection control pattern and connects the first metal pattern with the second metal pattern.

Abstract: Provided are novel selenyl-methyluracil compounds and a pharmaceutical composition for enhancing the effect of radiation treatment. The composition contains at least one compound selected from the group consisting of the selenyl-methyluracil compounds or pharmaceutically acceptable salts thereof, as an active ingredient.

Abstract: A method of manufacturing a liquid crystal display includes: preparing a lower mother substrate, where lower cells, each including a thin film transistor, are provided on the lower mother substrate, and a lower alignment layer is disposed on the lower cells; preparing an upper mother substrate, where upper cells corresponding to the lower cells are provided on the upper mother substrate, and an upper alignment layer is disposed on the upper cells; providing a mother substrate assembly by providing a liquid crystal mixture layer between the lower and upper mother substrates and combining the lower and upper mother substrates; providing a pretilt of the liquid crystals by applying a voltage to a voltage application unit of the lower mother substrate; and curing an alignment supporting agents in the liquid crystal mixture layer or the lower and upper alignment layers by irradiating light to a side of the mother substrate assembly.

Abstract: A transparent display panel includes a first substrate, a second substrate facing the first substrate, and a liquid crystal layer between the first substrate and the second substrate. The first substrate includes a gate line set including two gate lines; a data line set including two data lines; a pixel electrode in a unit pixel area; a switching element electrically connected to a gate line, a data line and the pixel electrode; and a black matrix on the gate line set and the data line set.

Abstract: A liquid crystal display includes: a first insulation substrate; a gate line disposed on the first insulation substrate; a first data line and a second data line disposed on the first insulation substrate; a color filter disposed on the first insulation substrate and disposed between the first data line and the second data line; a first light blocking member disposed on the first data line and the second data line; and a second light blocking member disposed on the color filter and the first light blocking member, extending in the same direction as the gate line, and overlapping the first light blocking member on the first data line and the second data line.

Abstract: A mobile terminal and a method of providing a video call using the same are disclosed. More particularly, a mobile terminal capable of supporting a video call while ensuring user's privacy by mounting a three-dimensional depth camera and a two-dimensional camera in the mobile terminal and a method of providing a video call using the same are disclosed. The mobile terminal of the present invention includes a 2D camera 200 capturing a 2D video and a 3D depth camera 210 capturing a 3D depth video; an individual image separation module 112 extracting boundary information between a user and a background by using depth information regarding a video captured by the 3D depth camera 210; a composite video generation module 114 separating the user video from the video captured by the 2D camera 200 by using the extracted boundary information and composing the separated user video and the set background video.

Abstract: Provided are novel selenyl-methyluracil compounds and a pharmaceutical composition for enhancing the effect of radiation treatment. The composition contains at least one compound selected from the group consisting of the selenyl-methyluracil compounds or pharmaceutically acceptable salts thereof, as an active ingredient.

Abstract: A display substrate includes a base substrate, a thin-film transistor (TFT), a color filter and a pixel electrode. The TFT is on the base substrate. The color filter is on the base substrate including the TFT and in contact with the base substrate. The pixel electrode is on the color filter and in electrical connection to a drain electrode of the TFT.

Abstract: The present disclosure relates to a spatial touch apparatus using a single infrared camera. More particularly, it relates to a spatial touch apparatus to implement a virtual touch screen in a free space by using an infrared light emitting diode (LED) array and a single infrared camera and to calculate X-axis and Z-axis coordinates of the infrared screen touched by a user indication object. Therefore, the present invention will provide tangible and interactive user interfaces to users and can implement more various user interfaces (UI) than a conventional 2D touch apparatus.

Abstract: The present invention relates to an apparatus for touching a projection of a 3D image on an infrared screen using a single-infrared camera, and more specifically to an apparatus for touching a projection of a 3D image, which projects an image in a free space; recognizes a position touched by a user on the projected image and thus can process an order from a user on the basis of the recognized touched position. The present invention can provide tangible and interactive user interfaces to users. In particular, it is possible to implement various UIs (User Interface), in comparison to an apparatus for touching a projection of a 2D image of the related art, by using the Z-axial coordinate on the infrared screen as the information on depth.